{Reference Type}: Journal Article
{Title}: Parkinsonism-dystonia-2: Case-series study from Saudi Arabia.
{Author}: Almuqbil MA;Tabassum S;Muthaffar OY;Ghamdi F;Al Masseri Z;Alsaman A;Alkhater RA;
{Journal}: Ann Clin Transl Neurol
{Volume}: 11
{Issue}: 4
{Year}: 2024 Apr 22
{Factor}: 5.43
{DOI}: 10.1002/acn3.52020
{Abstract}: Parkinsonism-dystonia-2 PKDYS2 is an autosomal-recessive disorder, caused by pathogenic biallelic variants in SLC18A2 which encodes the vesicular monoamine transporter (VMAT2) protein. PKDYS2 is a treatable neurotransmitter disease, and the rate of diagnosis of this disorder has increased significantly with the advance of genomic technologies. Our report highlights a novel pathologic variant in one case and a novel finding on MRI Brain, consisting of a normal symmetrical signal intensity in the dorsal brainstem and pons, and it substantiates the significance of genetic testing in the evaluation of children with developmental delays, which influences clinical decisions to enhance patient outcomes.